1. Home
  2. KLTOW vs PGYWW Comparison

KLTOW vs PGYWW Comparison

Compare KLTOW & PGYWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • PGYWW
  • Stock Information
  • Founded
  • KLTOW N/A
  • PGYWW 2016
  • Country
  • KLTOW United States
  • PGYWW United States
  • Employees
  • KLTOW 3
  • PGYWW 534
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • PGYWW Finance: Consumer Services
  • Sector
  • KLTOW Health Care
  • PGYWW Finance
  • Exchange
  • KLTOW Nasdaq
  • PGYWW Nasdaq
  • Market Cap
  • KLTOW N/A
  • PGYWW N/A
  • IPO Year
  • KLTOW 2022
  • PGYWW N/A
  • Fundamental
  • Price
  • KLTOW $0.02
  • PGYWW $0.11
  • Analyst Decision
  • KLTOW
  • PGYWW
  • Analyst Count
  • KLTOW 0
  • PGYWW 0
  • Target Price
  • KLTOW N/A
  • PGYWW N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • PGYWW 134.3K
  • Earning Date
  • KLTOW N/A
  • PGYWW 02-13-2025
  • Dividend Yield
  • KLTOW N/A
  • PGYWW N/A
  • EPS Growth
  • KLTOW N/A
  • PGYWW N/A
  • EPS
  • KLTOW N/A
  • PGYWW N/A
  • Revenue
  • KLTOW N/A
  • PGYWW $1,032,248,000.00
  • Revenue This Year
  • KLTOW N/A
  • PGYWW N/A
  • Revenue Next Year
  • KLTOW N/A
  • PGYWW N/A
  • P/E Ratio
  • KLTOW N/A
  • PGYWW N/A
  • Revenue Growth
  • KLTOW N/A
  • PGYWW 27.12
  • 52 Week Low
  • KLTOW N/A
  • PGYWW $0.15
  • 52 Week High
  • KLTOW N/A
  • PGYWW $0.23
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • PGYWW N/A
  • Support Level
  • KLTOW N/A
  • PGYWW N/A
  • Resistance Level
  • KLTOW N/A
  • PGYWW N/A
  • Average True Range (ATR)
  • KLTOW 0.00
  • PGYWW 0.00
  • MACD
  • KLTOW 0.00
  • PGYWW -0.01
  • Stochastic Oscillator
  • KLTOW 0.00
  • PGYWW 3.15

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About PGYWW Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, big data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.

Share on Social Networks: